Latest NewsAll News
mRNA vaccine technology is key to Africa’s public health independence
Sustained vaccine expertise, I.P, and manufacturing capacity required for vaccine sovereignty in Africa.
29 July 2026
Wits VIDA globally advances maternal vaccine to protect newborns from GBS
Wits VIDA plays central role in global effort to help protect newborns from sepsis due to Group B Streptococcus (GBS).
29 July 2026
Next-generation technologies take aim at hepatitis B
Four young scientists at AGTRU leverage vaccine science and gene therapy advances for novel treatment and prevention of hepatitis B.
28 July 2026
mRNA vaccine technology is key to Africa’s public health independence
Sustained vaccine expertise, I.P, and manufacturing capacity required for vaccine sovereignty in Africa.
29 July 2026
Wits VIDA globally advances maternal vaccine to protect newborns from GBS
Wits VIDA plays central role in global effort to help protect newborns from sepsis due to Group B Streptococcus (GBS).
29 July 2026
Next-generation technologies take aim at hepatitis B
Four young scientists at AGTRU leverage vaccine science and gene therapy advances for novel treatment and prevention of hepatitis B.
28 July 2026
Wits researchers won four national Science Oscars for work that improves lives. The University will lead a new South African-German renewable energy centre. Business leader Dr Reuel Khoza urges graduates to lead with integrity after receiving an honorary doctorate, while experts warned of a looming gas shortage in the near future. Eligible Wits retirees can now keep their Wits email address for life through a new university benefit.
WATCH
Straight From the ‘Gram